VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 210 filers reported holding VIR BIOTECHNOLOGY INC in Q4 2021. The put-call ratio across all filers is 1.43 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $35,822 | -61.8% | 3,823 | +0.0% | 0.00% | -100.0% |
| Q2 2023 | $93,754 | -10.7% | 3,822 | -15.3% | 0.00% | 0.0% |
| Q1 2023 | $104,948 | -20.6% | 4,510 | -13.6% | 0.00% | 0.0% |
| Q4 2022 | $132,144 | +30.8% | 5,221 | +0.1% | 0.00% | 0.0% |
| Q3 2022 | $101,000 | -22.3% | 5,218 | +1.9% | 0.00% | -50.0% |
| Q2 2022 | $130,000 | -0.8% | 5,121 | +0.4% | 0.00% | 0.0% |
| Q1 2022 | $131,000 | +1537.5% | 5,100 | +2671.7% | 0.00% | – |
| Q4 2021 | $8,000 | +166.7% | 184 | +183.1% | 0.00% | – |
| Q1 2021 | $3,000 | – | 65 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,559,142 | $36,281,234 | 32.04% |
| SB INVESTMENT ADVISERS (UK) LTD | 18,319,938 | $426,304,957 | 3.50% |
| Zebra Capital Management LLC | 27,110 | $631 | 3.15% |
| Avidity Partners Management LP | 1,640,200 | $38,167,454 | 1.27% |
| Sofinnova Investments, Inc. | 657,559 | $15,301,398 | 0.98% |
| DCF Advisers, LLC | 62,000 | $1,442,740 | 0.88% |
| SECTOR GAMMA AS | 145,545 | $3,386,832 | 0.82% |
| Temasek Holdings (Private) Ltd | 5,814,972 | $135,314,398 | 0.80% |
| BRAIDWELL LP | 604,036 | $14,055,918 | 0.46% |
| SummerHaven Investment Management, LLC | 26,045 | $606,067 | 0.35% |